Fund Holdings — TCG Crossover Management, LLC

Total Portfolio Value:
$733.09M
Total Bought:
$4.18M
Total Sold:
$25.34M
Net Transaction:
-$21.15M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CG Oncology, Inc.COMM(CGON)3,670,2063,670,2060$105.26M$89.88M12.26%-$15.38M
Cogent Biosciences, Inc.COMM(COGT)6,964,3756,964,3750$54.32M$41.72M5.69%-$12.61M
Centessa Pharmaceuticals PlcADRS2,890,8162,890,8160$48.42M$41.57M5.67%-$6.85M
Mineralys Therapeutics, Inc.COMM(MLYS)2,470,2652,470,2650$30.41M$39.23M5.35%+$8.82M
Ocular Therapeutix, Inc.COMM(OCUL)5,319,1485,319,1480$45.43M$38.99M5.32%-$6.44M
ABIVAX Société AnonymeADRS(ABVX)6,056,5966,056,5960$44.33M$37.85M5.16%-$6.48M
Savara Inc.COMM(SVRA)12,362,20512,362,2050$37.95M$34.24M4.67%-$3.71M
Dyne Therapeutics, Inc.COMM(DYN)2,650,1502,650,1500$62.44M$27.72M3.78%-$34.72M
Dianthus Therapeutics, Inc.COMM(DNTH)1,501,6241,501,6240$32.74M$27.24M3.72%-$5.50M
Tyra Biosciences, Inc.COMM(TYRA)1,989,1032,898,103+909,000$27.65M$26.95M3.68%-$696.2K
Xencor, Inc.COMM(XNCR)2,452,1382,452,1380$56.35M$26.09M3.56%-$30.26M
Disc Medicine, Inc.COMM(IRON)486,957465,257-21,700$30.87M$23.10M3.15%-$7.78M
Tourmaline Bio IncCOMM1,477,5931,477,5930$29.97M$22.47M3.07%-$7.49M
Cidara Therapeutics IncCOMM1,005,9011,005,9010$26.09M$21.67M2.96%-$4.43M
Amylyx Pharmaceuticals, Inc.COMM(AMLX)4,643,8125,943,812+1,300,000$17.55M$21.04M2.87%+$3.49M
Soleno Therapeutics IncCOMM550,000275,000-275,000$24.72M$19.65M2.68%-$5.07M
EyePoint, Inc.COMM(EYPT)3,572,3353,572,3350$26.61M$19.36M2.64%-$7.25M
Structure Therapeutics IncADRS1,063,0001,063,0000$28.83M$18.40M2.51%-$10.43M
Upstream Bio, Inc.COMM(UPB)2,801,7632,801,7630$44.86M$17.15M2.34%-$27.71M
RAPT Therapeutics, Inc.COMM13,135,26013,090,200-45,060$19.75M$15.97M2.18%-$3.78M
Fulcrum Therapeutics, Inc.COMM(FULC)5,250,0005,250,0000$24.68M$15.12M2.06%-$9.55M
Astria Therapeutics IncCOMM2,761,8612,761,8610$24.69M$14.75M2.01%-$9.94M
Tango Therapeutics, Inc.COMM(TNGX)10,736,00010,736,0000$33.17M$14.71M2.01%-$18.47M
COMPASS Pathways plcADRS(CMPS)3,858,0003,858,0000$14.58M$11.03M1.51%-$3.55M
Kura Oncology, Inc.COMM(KURA)1,423,6421,423,6420$12.40M$9.40M1.28%-$3.00M
Third Harmonic Bio IncCOMM2,505,4242,505,4240$25.78M$8.69M1.19%-$17.09M
Silence Therapeutics plcADRS(SLN)3,033,5603,033,5600$20.87M$8.55M1.17%-$12.32M
Adverum Biotechnologies IncCOMM1,796,4821,796,4820$8.39M$7.85M1.07%-$538.9K
Vistagen Therapeutics, Inc.COMM(VTGN)2,676,5802,676,5800$7.90M$6.69M0.91%-$1.20M
Aerovate Therapeutics IncCOMM2,240,8092,240,8090$5.94M$5.62M0.77%-$313.7K
Entrada Therapeutics, Inc.COMM(TRDA)584,955584,9550$10.11M$5.29M0.72%-$4.83M
MBX Biosciences, Inc.COMM(MBX)650,000650,0000$11.98M$4.80M0.65%-$7.18M
Avalo Therapeutics, Inc.COMM(AVTX)483,000483,0000$3.59M$3.87M0.53%+$280.1K
Kodiak Sciences Inc.COMM(KOD)1,145,5381,145,5380$11.40M$3.21M0.44%-$8.18M
Nektar TherapeuticsCOMM(NKTR)4,000,0004,000,0000$3.72M$2.72M0.37%-$1.00M
Ventyx Biosciences IncCOMM316,195316,1950$692.5K$363.6K0.05%-$328.8K
Cabaletta Bio, Inc.COMM(CABA)86,79586,7950$197.0K$120.2K0.02%-$76.8K
Keros Therapeutics, Inc.COMM(KROS)550,0000-550,000$8.71M$0—-$8.71M
Page 1 of 1
TCG Crossover Management, LLC — 13F Holdings — Q1 2025 | TickerTrail